首页 | 本学科首页   官方微博 | 高级检索  
     

葡糖胺聚糖对糖尿病肾病UAER、胰岛素抵抗和CRP的影响
引用本文:陈思娇,张绍维,魏敏,熊盈,高阳,胡怡,李廷富,李恂,马建忠,宋今丹. 葡糖胺聚糖对糖尿病肾病UAER、胰岛素抵抗和CRP的影响[J]. 中国老年学杂志, 2007, 27(18): 1779-1781
作者姓名:陈思娇  张绍维  魏敏  熊盈  高阳  胡怡  李廷富  李恂  马建忠  宋今丹
作者单位:1. 中国医科大学附属第一医院老年病教研室,辽宁,沈阳,110001
2. 解放军第202医院内分泌科
3. 中国医科大学
4. 沈阳市疾病预防控制中心慢病科
5. 中国医科大学数学统计教研室
6. 中国医科大学卫生部细胞生物学重点实验室
基金项目:辽宁省教育厅攻关项目(05l494),辽宁省自然科学基金(20062102)
摘    要:目的探讨葡糖胺聚糖(GAGs)早期糖尿病肾病(DN)作用。方法60例2型糖尿病肾病患者,24 h尿白蛋白排泄率(UAER)30~300 mg。随机分为常规组(R组)、氯沙坦钾组(C组)、GAGs组(G组)。检测指标包括UAER、胰岛素抵抗(IR)指数(IRI)、C反应蛋白(CRP)、凝血三项、血脂、血糖、C肽、肝肾功能等。结果1.凝血三项:三组组内治疗前后各自比较,G组,差异显著(P<0.01);R组和C组,差异不显著(P>0.05);G组分别与R组和C组两组治疗后比较,差异显著(P<0.01)。2.CRP、UAER、IRI:三组组内治疗前后各自比较,G组和C组,差异显著(P<0.01);R组,差异不显著(P>0.05);G组分别与R组和C组两组治疗后比较,差异显著(P<0.01)。3.FBG、C肽-及HbA1 c:三组组内治疗前后各自比较,G组和C组,差异显著(P<0.01);R组,差异不显著(P>0.05)。4.三组血压、血脂、肝肾功各指标治疗前后比较,差异均不显著(P>0.05);G组与R组治疗后比较,差异显著(P<0.01);G组与C组治疗后比较,差异不显著(P>0.05)。结论GAGs能够减少微量白蛋白尿期DN患者的UAER,改善IR,降低血清CRP。对血压、血脂、肝肾功能无影响。

关 键 词:糖尿病肾病(DN)  葡糖胺聚糖(GAGs)  尿白蛋白排泄率(UAER)  C反应蛋白(CRP)  胰岛素抵抗指数(IRI)
文章编号:1005-9202(2007)18-1779-03
收稿时间:2006-05-26
修稿时间:2007-07-12

Glycosaminoglycans on CRP and UAER of early diabetic nephropathy
CHEN Si-Jiao, ZHANG Shao-Wei, WEI MIN,et al.. Glycosaminoglycans on CRP and UAER of early diabetic nephropathy[J]. Chinese Journal of Gerontology, 2007, 27(18): 1779-1781
Authors:CHEN Si-Jiao   ZHANG Shao-Wei   WEI MIN  et al.
Affiliation:Teaching and Research Office for Geriatric Disease of the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China
Abstract:Objective To observe the therapeutic effect of glycosaminoglycans(GAGs) on diabetes mellitus(DM) with early nephropathy in order to find a new therapeutic approach to diabetic nephropathy(DN).Methods 60 cases of type 2 DN(albuminuria: 30 to 300 mg/24 h) without hypertension were randomly divided into routine group,cozaar(losartan potassium) group and GAGs group.Insulin resistant index(IRI),C reactive protein(CRP),urinary albumin excretion rate(UAER),blood clotting indexes and blood fat,blood glucose and C peptide and hepatic,kidney function were tested.Results After three months treatment,the levels of UAER were decreased significantly in both GAGs group and Cozaar group(P<0.01). During the three months UAER was lowering step by step,and there was no difference between them.The levels of UAER had no changes in regular group and there was significant difference from that in the former two groups.In GAGs group,the levels of whole blood viscosity of medium shear rate,whole blood viscosity of medium sheer rate,whole blood viscosity of low shear rate were declined significantly;that of plasma viscosity,whole blood reduced viscosity,CRP,IRI were all decreased to some degree.BUN,Cr,fasting serum C peptide and blood pressure etc had no change among three groups before and after observation.Conclusions GAGs has the therapeutic effect on type 2 DN patients with microalbuminuria because of its effect of decreasing UAER,CRP,IRI and it can postpone or reverse the development of DN.
Keywords:Diabetic nephropathy(DN)  Glycosaminoglycans(GAGs)  Urinary albumin excretion rate(UAER)  C reactive protein(CRP)  Insulin resistant index(IRI)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号